Redeye sees the successful completion of stage one of LIDDS' collaboration with Johnson & Johnson, as well as the decision to continue, as a validation of the NanoZolid platform.
ANNONS
Redeye sees the successful completion of stage one of LIDDS' collaboration with Johnson & Johnson, as well as the decision to continue, as a validation of the NanoZolid platform.